AngioDynamics (NASDAQ:ANGO) Rating Reiterated by HC Wainwrig

HC Wainwright restated their buy rating on shares of AngioDynamics (NASDAQ:ANGO – Free Report) in a research report report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $14.00 target price on the medical instruments supplier’s stock. HC Wainwright also issued estimates for AngioDynamics’ Q4 2024 earnings at ($0.21) EPS, Q2 2025 earnings […]

Related Keywords

United States , Jamesc Clemmer , , Angiodynamics Company Profile , Securities Exchange Commission , Angiodynamics Inc , Acadian Asset Management , Acuitas Investments , Sg Capital Management , Jacobs Levy Equity Management Inc , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Asset Management , Jacobs Levy Equity Management , Levy Equity Management , Auryon Atherectomy , Angiodynamics Daily ,